China Universal Asset Management Co. Ltd. grew its holdings in Lam Research Corporation (NASDAQ:LRCX – Free Report) by 42.4% in the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 49,911 shares of the semiconductor company’s stock after acquiring an additional 14,869 shares during the period. China Universal Asset Management Co. Ltd.’s holdings in Lam Research were worth $6,694,000 as of its most recent SEC filing.
Several other hedge funds also recently modified their holdings of LRCX. Howard Hughes Medical Institute acquired a new position in Lam Research during the second quarter worth $27,000. Sound Income Strategies LLC bought a new stake in shares of Lam Research during the 3rd quarter worth about $41,000. Tripletail Wealth Management LLC bought a new stake in shares of Lam Research during the 3rd quarter worth about $44,000. Strategic Wealth Investment Group LLC acquired a new position in shares of Lam Research during the 2nd quarter valued at about $29,000. Finally, Delos Wealth Advisors LLC bought a new position in shares of Lam Research in the 2nd quarter valued at approximately $30,000. Institutional investors and hedge funds own 84.61% of the company’s stock.
Insider Activity
In related news, Director Eric Brandt sold 35,000 shares of the firm’s stock in a transaction that occurred on Friday, February 6th. The stock was sold at an average price of $225.60, for a total transaction of $7,896,000.00. Following the completion of the transaction, the director owned 253,705 shares in the company, valued at $57,235,848. This trade represents a 12.12% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Insiders own 0.31% of the company’s stock.
Lam Research Price Performance
Lam Research (NASDAQ:LRCX – Get Free Report) last posted its quarterly earnings results on Wednesday, January 28th. The semiconductor company reported $1.27 earnings per share for the quarter, topping analysts’ consensus estimates of $1.17 by $0.10. Lam Research had a net margin of 30.22% and a return on equity of 62.81%. The firm had revenue of $5.34 billion for the quarter, compared to the consensus estimate of $5.23 billion. During the same quarter in the previous year, the company earned $0.91 earnings per share. The business’s revenue was up 22.1% compared to the same quarter last year. Lam Research has set its Q3 2026 guidance at 1.250-1.450 EPS. Sell-side analysts predict that Lam Research Corporation will post 3.71 earnings per share for the current year.
Lam Research Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 8th. Stockholders of record on Wednesday, March 4th will be paid a $0.26 dividend. This represents a $1.04 annualized dividend and a dividend yield of 0.4%. The ex-dividend date is Wednesday, March 4th. Lam Research’s dividend payout ratio is currently 21.31%.
Analyst Upgrades and Downgrades
Several equities analysts have commented on LRCX shares. The Goldman Sachs Group set a $262.00 price target on Lam Research and gave the company a “buy” rating in a report on Thursday, January 29th. Jefferies Financial Group reiterated a “buy” rating and issued a $200.00 target price (up from $175.00) on shares of Lam Research in a research note on Monday, December 15th. Wall Street Zen downgraded shares of Lam Research from a “buy” rating to a “hold” rating in a report on Saturday, November 8th. JPMorgan Chase & Co. upped their price target on shares of Lam Research from $165.00 to $300.00 and gave the company an “overweight” rating in a report on Thursday, January 29th. Finally, Needham & Company LLC lifted their price objective on Lam Research from $250.00 to $300.00 and gave the stock a “buy” rating in a research note on Thursday, January 29th. One analyst has rated the stock with a Strong Buy rating, twenty-eight have issued a Buy rating and six have issued a Hold rating to the company. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $244.88.
Read Our Latest Stock Report on LRCX
Lam Research Company Profile
Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.
Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.
See Also
- Five stocks we like better than Lam Research
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
- Unlocked: Elon Musk’s Next Big IPO
- My Epstein Story
- This $15 Stock Could Go Down as the #1 Stock of 2026
- What a Former CIA Agent Knows About the Coming Collapse
Want to see what other hedge funds are holding LRCX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Lam Research Corporation (NASDAQ:LRCX – Free Report).
Receive News & Ratings for Lam Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lam Research and related companies with MarketBeat.com's FREE daily email newsletter.
